Sequent Scientific Ltd Stock Analysis

BSE: 512529 | NSE: SEQUENT | Pharmaceuticals & Drugs | Small Cap

BSE Share Price 03-Feb-2023 18:01
74.20 -1.85 (-2.43%)

DeciZen - Make an Informed Decision on Sequent Scientific

Overall Rating

1. Quality

2. Valuation


3. Price Trend

Sequent Scientific Price Chart

P/E Ratio ( CD) :
Market Cap :
1,850.8 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Sequent Scientific Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Sequent Scientific Ltd is a average quality company.

2. Is Sequent Scientific Ltd undervalued or overvalued?

The key valuation ratios of Sequent Scientific Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Sequent Scientific Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sequent Scientific Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Sequent Scientific:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Sequent Scientific Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

ROCE % -9%-8.3%-1.1%0.7%1.2%13.8%7.4%9.2%11.5%4.6%-
Value Creation Index -1.6-1.6-1.1-1.0-0.9-0.0-0.5-0.4-0.2-0.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 3274554656256841,0311,0391,1791,3621,4131,421
YoY Gr. Rt. %-39.4%2.2%34.3%9.4%50.8%0.9%13.5%15.5%3.8%-
Adj EPS -5-4.7-2.5-0.9-
YoY Gr. Rt. %-NANANANANA-61.7%36.4%39.2%-64.1%-
BVPS (₹) 7.123.838.739.425.927.927.1292629.6
Adj Net Profit -59.5-64.2-37.8-20.5-4.113853.673.410236.78
Cash Flow from Ops. -3.8-44.8-23.6-0.1-7.245.211611511530.6-
Debt/CF from Ops. -81.5-9.3-20.1-5782.5-


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 17.7%15.6%10.8%3.8%
Adj EPS NANA-12%-64.1%
BVPS 15.5-8-2.3-10.4
Share Price 7.8% 0.4% -6.4% -53.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity % -54.7-84.6-51.1-4-0.4177.910.514.55.21.2
Op. Profit Mgn % -
Net Profit Mgn % -18.2-14.1-8.4-3-114.367.
Debt to Equity 3.715.
Working Cap Days 251210233224314226206190183200205
Cash Conv. Cycle 613617693707973839872

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 10.78%

Return on Equity has declined versus last 3 years average to 1.20%

Net Profit has been subdued in last 3 years -11.98%

Sales growth is not so good in last 4 quarters at 2.42%

Latest Financials - Sequent Scientific Ltd.

Standalone Consolidated
TTM EPS (₹) 0.3 0.3
TTM Sales (₹ Cr.) 242 1,421
BVPS (₹.) 41.9 29.6
Reserves (₹ Cr.) 995 688
P/BV 1.77 2.51
PE 233.95 223.63
From the Market
52 Week Low / High (₹) 74.20 / 166.90
All Time Low / High (₹) 0.40 / 336.40
Market Cap (₹ Cr.) 1,851
Equity (₹ Cr.) 49.9
Face Value (₹) 2
Industry PE 36.3

Management X-Ray of Sequent Scientific :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Sequent Scientific

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


Sequent Scientific Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Sequent Scientific on 03-Feb-2023 18:01 is : 74.20.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Feb-2023 18:01 the market cap of Sequent Scientific stood at ₹ 1,850.8.
The latest PE ratio of Sequent Scientific as of 03-Feb-2023 18:01 is 233.9.
The latest PB ratio of Sequent Scientific as of 03-Feb-2023 18:01 is 1.77
The 52-week high of Sequent Scientific is ₹ 166.9 and the 52-week low is ₹ 74.20.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Sequent Scientific is ₹ 242.0 ( Cr.) .

About Sequent Scientific Ltd

P I Drugs & Pharmaceuticals Ltd. established in 1991 is a leading manufacturer, exporter of specialized quality formulations having an objective of fulfilling the diverse demands of pharmaceutical industry.

P I Drugs & Pharmaceuticals Ltd. specializes in the manufacturing of the formulation belonging to anthelmintic & anti-parasitic segment.

In September 2007 PI Drugs purchased the pharma division of Transchem Limited.

The company is engaged in the business of human health & animal health and enjoys high Image for distribution in domestic as well as international markets.

They have a specialized and dedicated WHO - GMP accredited manufacturing plant for the manufacture of API's. It exports to all major markets like Europe, South America, Australia, Asia and Africa.

They started with the introduction of Albendazole and has developed core competency in chemistry of Benzimadazole in very short time.

Product range of the company includes:

Human / Veterinary Formulations

  • Diminazene Diaceturate
  • Toldimfos Sodium
  • Quinapyramine
  • Triclabendazole
  • Albendazole
  • Fenbendazole
  • Oxyclozanide
  • Niclosamide
  • Frusemide
  • Mebendazole

Honey Bee Medicine

  • Pizitol®
  • Apistonic®
  • Transprim®

Human / Veterinary API's

Veterinary API’s

  • Albendazole USP/EP/BP
  • Fenbendazole BP/ EP/BP VET
  • Oxfendazole EP/BP VET
  • Mebendazole USP/EP/BP/POLY 'C'

Human API's 

  •  Pentamidine Isethionate
  •  Ramipril EP / BP
  •  Frusemide USP / EP / BE
  •  Cetrizine DI HCL BP / EP
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now